MNKD

MannKind Corp (MNKD)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 1.69B
P/E Ratio
48.55
Revenue (TTM)
$ 301.74M
Volume
0
52W High
$ 7.63
52W Low
$ 3.38
Dividend Yield
0.00%
Beta
1.02

Technicals

50-Day MA
3.9532
200-Day MA
5.0241
52 Week High
7.63
52 Week Low
3.3812

About MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It.

Employees
403
Headquarters
Danbury, CT
CEO
Dr. Michael E. Castagna Pharm.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg